Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections

被引:18
|
作者
Shaikh, Safia Bader Uddin [1 ]
Ahmed, Zafar [1 ]
Arsalan, Syed Ali [1 ]
Shafiq, Sana [1 ]
机构
[1] Liaquat Natl Hosp, Dept Pulmonol, Karachi, Pakistan
来源
关键词
community-acquired lower respiratory tract infections or pneumonia; M; catarrhalis; antibiotic resistance; gram-negative diplococcic; Pakistan; OBSTRUCTIVE PULMONARY-DISEASE; ANTIMICROBIAL RESISTANCE; HAEMOPHILUS-INFLUENZAE; ACUTE EXACERBATIONS; PNEUMONIA; CHILDREN; COPD;
D O I
10.2147/IDR.S84209
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Moraxella catarrhalis previously considered as commensal of upper respiratory tract has gained importance as a pathogen responsible for respiratory tract infections. Its beta-lactamase-producing ability draws even more attention toward its varying patterns of resistance. Methods: This was an observational study conducted to evaluate the prevalence and resistance pattern of M. catarrhalis. Patients aged 20-80 years admitted in the Department of Chest Medicine of Liaquat National Hospital from March 2012 to December 2012 were included in the study. Respiratory samples of sputum, tracheal secretions, and bronchoalveolar lavage were included, and their cultures were followed. Results: Out of 110 respiratory samples, 22 showed positive cultures for M. catarrhalis in which 14 were males and eight were females. Ten samples out of 22 showed resistance to clarithromycin, and 13 samples out of 22 displayed resistance to erythromycin, whereas 13 showed resistance to levofloxacin. Hence, 45% of the cultures showed resistance to macrolides so far and 59% showed resistance to quinolones. Conclusion: Our study shows that in our environment, M. catarrhalis may be resistant to macrolides and quinolones; hence, these should not be recommended as an alternative treatment in community-acquired lower respiratory tract infections caused by M. catarrhalis. However, a study of larger sample size should be conducted to determine if the recommendations are required to be changed.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 50 条
  • [41] Antibiotic resistance in community-acquired urinary tract infections: Prevalence and risk factors
    Kurtaran, Behice
    Candevir, Aslihan
    Tasova, Yesim
    Kibar, Filiz
    Inal, Ayse Seza
    Komur, Suheyla
    Aksu, Hasan Salih Zeki
    MEDICAL SCIENCE MONITOR, 2010, 16 (05): : CR246 - CR251
  • [42] Chest CT Features of Community-acquired Respiratory Viral Infections in Adult Inpatients With Lower Respiratory Tract Infections
    Shiley, Kevin T.
    Van Deerlin, Vivianna M.
    Miller, Wallace T., Jr.
    JOURNAL OF THORACIC IMAGING, 2010, 25 (01) : 68 - 75
  • [43] Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007
    Morrissey, Ian
    Maher, Kirsty
    Williams, Laura
    Shackcloth, Jemma
    Felmingham, David
    Reynolds, Rosy
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 : II97 - II103
  • [44] Surveillance of antimicrobial resistance of community-acquired lower respiratory pathogens:: Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Dakar/Senegal (1999-2000)
    Boye, CS
    Pouye, A
    Hanne, AA
    Ba, M
    Sow, PS
    Francisco, S
    Dia, Y
    Labou, A
    12TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 2000, : 3 - 7
  • [45] The aetiological agents in adult patients with community-acquired lower respiratory tract infections in Turkey
    Koksal, I.
    Ozlu, T.
    Saral, O. Bayraktar
    Aydin, K.
    Caylan, R.
    Oztuna, F.
    Bulbul, Y.
    Yilmaz, G.
    Sucu, N.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S327 - S328
  • [46] New antibiotics for community-acquired lower respiratory tract infections: improved activity at a cost?
    Ball, P
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (03) : 263 - 272
  • [47] CLINICAL-EVALUATION OF PEFLOXACIN IN COMMUNITY-ACQUIRED LOWER RESPIRATORY-TRACT INFECTIONS
    VANDERDONCKT, J
    HELLEBRAND, A
    CORDIER, R
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1988, 43 (01): : 82 - 91
  • [48] Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
    Gardiner, Samantha J.
    Gavranich, John B.
    Chang, Anne B.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (01):
  • [49] TREATMENT OF COMMUNITY-ACQUIRED LOWER RESPIRATORY-TRACT INFECTIONS WITH ORAL CEFUROXIME AXETIL
    LIMSON, BM
    GARVEZ, MD
    CLINICAL THERAPEUTICS, 1990, 12 (05) : 436 - 439
  • [50] Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
    Mulholland, Selamawit
    Gavranich, John B.
    Gillies, Malcolm B.
    Chang, Anne B.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):